Alivus Life Sciences

1,142.60
-63.40
(-5.26%)
Market Cap
14,778.00 Cr
EPS
38.43
PE Ratio
33.49
Dividend Yield
1.86 %
Industry
Healthcare
52 Week High
1,251.00
52 Week Low
850.00
PB Ratio
5.83
Debt to Equity
0.01
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Alivus Life Sciences Reports Q4 Results and Dividend Recommendation23 hours ago
Alivus Life Sciences announced its Q4 financial results and dividend recommendation. The company's Q4 EBITDA increased to 1.98 billion rupees from 1.41 billion rupees year-over-year, with EBITDA margin improving to 30.56% from 26.36%. Q4 net profit rose to 1.4 billion rupees from 980 million rupees year-over-year, remaining stable quarter-on-quarter. Revenue for Q4 grew to 6.5 billion rupees from 5.36 billion rupees year-over-year. The company has recommended a dividend of 5 rupees per equity share.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,734.90
#1 4,17,508.30
35.39
#1 49,887.20
12.06
#1 9,648
13.77
47.70
6,279.50
1,64,975.40
79.75
8,184.00
0.89
1,600
64.53
62.83
1,499.90
1,21,319.90
23.01
26,520.70
14.17
4,155
30.28
49.42
3,266.80
1,10,502.40
59.35
10,785.70
11.59
1,656
13.54
52.85
2,572.70
1,05,616.00
51.74
10,615.60
19.57
1,942
-16.38
59.84
1,230.70
1,03,163.70
#1 18.22
28,905.40
12.36
5,578
21.14
64.04
2,068.40
94,636.40
28.82
20,141.50
#1 19.94
1,936
#1 112.49
52.76
902.70
91,034.00
20.07
19,831.50
13.82
3,831
29.92
56.61
1,201.20
70,677.70
20.05
29,559.20
17.55
3,169
-10.04
51.74
30,560.00
64,449.10
48.36
6,097.20
10.80
1,201
27.83
54.55
Forecast
Actual
Growth Rate
Revenue Growth
4.80 %
Net Income Growth
0.84 %
Cash Flow Change
35.13 %
ROE
-7.55 %
ROCE
-8.03 %
EBITDA Margin (Avg.)
-2.45 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
0
887
1,549
1,886
2,138
2,190
2,295
2,421
Expenses
0
639
1,065
1,294
1,507
1,519
1,609
1,704
EBITDA
0
248
484
592
631
671
686
717
Operating Profit %
-5 %
28 %
31 %
31 %
29 %
30 %
30 %
29 %
Depreciation
0
19
29
33
38
42
54
61
Interest
0
1
34
88
28
1
2
2
Profit Before Tax
0
228
421
471
565
629
631
654
Tax
0
33
108
119
146
162
160
162
Net Profit
-0
196
313
352
419
467
471
486
EPS in ₹
-7.89
24.64
29.04
32.61
35.63
38.11
38.43
39.60

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
0
1,475
1,726
1,997
2,471
2,702
2,850
Fixed Assets
0
456
546
573
590
781
805
Current Assets
0
931
1,160
1,399
1,765
1,850
1,916
Capital Work in Progress
0
80
11
14
97
62
106
Investments
0
0
0
0
0
0
0
Other Assets
0
939
1,169
1,410
1,784
1,860
1,939
Total Liabilities
0
1,475
1,726
1,997
2,471
2,702
2,850
Current Liabilities
2
1,380
1,308
1,221
384
497
439
Non Current Liabilities
0
7
16
23
33
67
79
Total Equity
-1
88
402
753
2,054
2,138
2,332
Reserve & Surplus
-1
86
400
751
2,030
2,114
2,308
Share Capital
0
2
2
2
25
25
25

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
2
8
106
397
-228
18
Investing Activities
0
-9
-51
-69
-122
-147
-117
Operating Activities
-1
10
195
388
598
306
414
Financing Activities
1
1
-137
-214
-79
-388
-279

Share Holding

% Holding
Apr 2021
Aug 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
100.00 %
82.84 %
82.84 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
75.00 %
75.00 %
74.99 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.00 %
4.38 %
0.00 %
5.01 %
4.82 %
7.85 %
6.74 %
6.57 %
DIIs
0.00 %
1.34 %
0.30 %
0.32 %
0.50 %
0.71 %
0.79 %
0.09 %
0.00 %
0.58 %
0.64 %
0.59 %
1.40 %
1.57 %
4.16 %
4.86 %
5.19 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
7.99 %
7.97 %
7.72 %
7.80 %
8.14 %
9.14 %
9.77 %
10.87 %
10.02 %
9.20 %
9.20 %
9.09 %
9.13 %
10.63 %
10.99 %
10.50 %
Others
0.00 %
7.83 %
8.89 %
9.11 %
8.86 %
8.31 %
7.21 %
7.29 %
6.28 %
6.55 %
2.92 %
7.36 %
1.64 %
1.64 %
2.36 %
2.41 %
2.74 %
No of Share Holders
7
3,73,362
2,80,300
2,53,726
2,38,578
2,33,538
2,32,203
2,25,730
2,22,866
2,08,267
1,98,764
1,85,531
1,56,183
1,49,396
1,43,960
1,46,840
1,41,977

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 21 42 22.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 5.49 5.41 2.08 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,110.95 1,180.60
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jan 2025 1,065.60 1,122.65
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 1,173.20 1,073.35
09 Oct 2024 CHANGE OF NAME Change Of Name
NA
09 Oct 2024 1,203.25 1,203.25
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 1,076.05 1,107.00
17 Oct 2023 DIVIDEND Dividend
₹ 22.50 /share
17 Oct 2023 624.60 667.90
24 Mar 2023 DIVIDEND Dividend
₹ 21.00 /share
24 Mar 2023 382.65 413.10
17 Sept 2022 DIVIDEND Dividend
₹ 10.50 /share
15 Sept 2022 489.00 418.95
23 Nov 2021 DIVIDEND Dividend
₹ 10.50 /share
22 Nov 2021 637.10 611.65

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome7 hours ago
Announcement under Regulation 30 (LODR)-Investor Presentation22 hours ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release23 hours ago
Appointment Of Secretarial Auditor23 hours ago
Announcement under Regulation 30 (LODR)-Change in Directorate23 hours ago
Corporate Action-Board to consider Dividend23 hours ago
Board Meeting Outcome for Audited Financial Results For The Fourth Quarter And Year Ended March 31 202523 hours ago
Audited Financial Results For The Fourth Quarter And Year Ended March 31 202523 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
Closure of Trading Window8 days ago
Board Meeting Intimation for To Consider And Approve The Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2025 And To Consider And Recommend Dividend If Any On Equity Shares For The Year Ended March 31 2025.8 days ago
Compliances-Reg.24(A)-Annual Secretarial Compliance8 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 30, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 17, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 03, 2025
Announcement under Regulation 30 (LODR)-AcquisitionApr 02, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 03, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 27, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 21, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 31, 2025
Transcript Of Earnings Call.Jan 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2025
Integrated Filing (Financial)Jan 23, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 23, 2025
Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2024Jan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 17, 2025
Closure of Trading WindowJan 16, 2025
Board Meeting Intimation for Inter Alia To Consider And Approve The Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended 31St December 2024Jan 16, 2025
Announcement under Regulation 30 (LODR)-Change of Company NameDec 17, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 27, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 22, 2024
Transcript Of Earning CallOct 31, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 26, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 25, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 25, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 24, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 24, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 24, 2024
Unaudited Finanacial Results For The Second Quarter And Half Year Ended 30Th September 2024.Oct 24, 2024
Disclosure Pursuant To Regulation 31A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended (SEBI Listing Regulations') - Re-Classification From 'Promoter Group' Category To 'Public Category' Of Glenmark Life Sciences Limited ('The Company')Oct 22, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 18, 2024

Technical Indicators

RSI(14)
Neutral
70.81
ATR(14)
Volatile
51.84
STOCH(9,6)
Neutral
75.20
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
13.31
ADX(14)
Weak Trend
19.13
UO(9)
Bearish
64.27
ROC(12)
Uptrend But Slowing Down
10.57
WillR(14)
Overbought
-9.49